Tomorrow Investor

Found Industries and ARES Strategic Mining Sign MOU to Advance Domestic Gallium, Germanium and Fluorspar Recovery from Utah’s Lost Sheep Mine

Found Industries Announces MOU with ARES for Gallium Recovery | TheNewswire

Found to evaluate resin-free electrochemical Direct Feedstock Extraction technology at the only currently permitted fluorspar mine in the United States Boston, MA / Juab County, Utah – TheNewswire – May 12, 2026 — Found Industries, through its Found Metals division, and ARES Strategic Mining Inc. (CSE: ARS) (OTC: ARSMF) (FRA: N8I1) today announced the signing of a Memorandum of Understanding to evaluate the recovery of gallium, germanium and other strategic critical materials from ARES-owned or controlled feedstocks associated with the Lost Sheep Mine in Utah.

This excerpt is quoted from the original release. Read the full announcement on TheNewswire.

Brief Summary

Found Industries and ARES Strategic Mining have signed a Memorandum of Understanding (MOU) aimed at leveraging innovative technologies to recover valuable minerals including gallium and germanium. Key highlights include:

  • Innovative Technology: Evaluation of resin-free electrochemical Direct Feedstock Extraction technology.
  • Strategic Location: The Lost Sheep Mine is the only currently permitted fluorspar mine in the U.S.
  • Material Recovery: Focused on critical materials to support domestic supply chains.

Why it matters: This partnership positions both companies for significant advancements in the recovery of essential materials amidst growing demand.

Read the Full Article

This is a summary of the press release. For the complete article and any additional details, please visit the original source.

Read Full Article

Attribution: Original press release by TheNewswire on . We provide an AI-generated summary and links for convenience. Always verify details with the original source. Not investment advice. For informational purposes only.

Tomorrow Investor
The Tomorrow Investor

Markets research for retail investors

Independent coverage of small-cap equities, biotech catalysts, and emerging market opportunities.